Healthcare Services company Dr. Lal Pathlabs announced Q1FY26 results Revenue increased by 11.3% in Q1FY26 to Rs 670 crore. EBITDA increased by 13.1% with a margin of 28.7%. PAT increased by 24.3% to Rs 134 crore, with a margin for of 20.0%. Interim Dividend of Rs 6 per share for Q1FY26. Result PDF